Back to Zürcher Kantonalbank Zürcher Kantonalbank

KNSA

8 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Kiniksa Pharmaceuticals International, plc

Yes. Zürcher Kantonalbank holds 15,111 shares of KNSA (Kiniksa Pharmaceuticals International), worth $966,348, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Zürcher Kantonalbank has held KNSA since Q3 2024, across 8 quarterly 13F filings.

Current Value

$966,348

Current Shares

15,111

Total Value Change

+$777,599

Total Shares Change

+7,558

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
15,111
0.0%
$966,3480.0%$63.95
0
2026-Q1
Decreased
15,111
-10.8%
$727,5950.0%$48.15
0
2025-Q4
Increased
16,933
+9.3%
$698,4860.0%$41.25
27
2025-Q3
Unchanged
15,487
0.0%
$601,3600.0%$38.83
0
2025-Q2
Unchanged
15,487
0.0%
$428,5250.0%$27.67
0
2025-Q1
Unchanged
15,487
0.0%
$343,9660.0%$22.21
0
2024-Q4
Increased
15,487
+105.0%
$306,3330.0%$19.78
38
2024-Q3
New
7,553
-
$188,7490.0%$24.99
31

Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used